Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (71)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SEAR, J. W.
Right arrow Articles by McQUAY, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEAR, J. W.
Right arrow Articles by McQUAY, H. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1989, Vol. 62, No. 1 28-32
© 1989 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

STUDIES ON MORPHINE DISPOSITION: INFLUENCE OF RENAL FAILURE ON THE KINETICS OF MORPHINE AND ITS METABOLITES

J. W. SEAR, M.A., B.SC., PH.D., F.F.A.R.C.S., C. W. HAND, D.PHIL., G.R.S.C.*, R. A. MOORE, D.PHIL., F.R.S.C.* and H. J. McQUAY, D.M., F.F.A.R.C.S.

Nuffield Departments of Anaesthetics and Clinical Biochemistry, John Radcliffe Hospital Heading-ton, Oxford OX3 9DU

The influence of renal failure on the disposition of morphine and its metabolites was studied in nine patients with end-stage renal failure undergoing transplantation, and compared with five healthy anaesthetized patients. All patients received morphine sulphate pentahydrate 10 mg i. v. over 30 s, as part of a balanced anaesthetic technique. Venous blood samples were collected for up to 24 h, and plasma concentrations of morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) assayed by a differential radioimmunoassay method. There were no differences between the two groups for morphine elimination half-life (renal failure: 290 min: anaesthetized controls: 286min), or clearance (renal failure: 533 ml min–1: controls 741 ml min–1). However, the volume of distribution at steady state was greater in the control group (241 litre v. 141 litre; P = 0.002). The peak concentrations of M3G and M6G were greater in the renal transplant patients (P = 0.001 and P = 0.01, respectively), as were the AUC (0–24 h) (P = 0.002 and P = 0.002). M6G has been shown to possess analgesic properties in both man and experimental animals, and therefore the increased AUC for M6G may contribute to the prolonged effect seen with morphine when given to patients with impaired renal function.

*Present address: DPC-ERI, Station Road, Witney, Oxon.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
H. S. Smith
Opioid Metabolism
Mayo Clin. Proc., July 1, 2009; 84(7): 613 - 624.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. G. Craig and J. M. Hunter
Recent developments in the perioperative management of adult patients with chronic kidney disease
Br. J. Anaesth., September 1, 2008; 101(3): 296 - 310.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. A. Grass
Patient-Controlled Analgesia
Anesth. Analg., November 1, 2005; 101(5S_Suppl): S44 - 61.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. W. Sear
Kidney dysfunction in the postoperative period
Br. J. Anaesth., July 1, 2005; 95(1): 20 - 32.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
M A Lee, M E F Leng, and R M Cooper
Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis
Palliative Medicine, April 1, 2005; 19(3): 259 - 260.
[Abstract] [PDF]


Home page
JCOHome page
S. Mercadante, A. Casuccio, F. Fulfaro, L. Groff, R. Boffi, P. Villari, V. Gebbia, and C. Ripamonti
Switching From Morphine to Methadone to Improve Analgesia and Tolerability in Cancer Patients: A Prospective Study
J. Clin. Oncol., June 1, 2001; 19(11): 2898 - 2904.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
M. A Lee, M. E F Leng, and E. J J Tiernan
Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine
Palliative Medicine, January 1, 2001; 15(1): 26 - 34.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
C. J. Diskin and S. Thomas
Intravenous analgesic use in dialysis patients
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2530 - 2532.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Kostopanagiotou, V. Smyrniotis, N. Arkadopoulos, K. Theodoraki, L. Papadimitriou, and J. Papadimitriou
Anesthetic and Perioperative Management of Adult Transplant Recipients in Nontransplant Surgery
Anesth. Analg., September 1, 1999; 89(3): 613 - 613.
[Full Text] [PDF]


Home page
Palliat MedHome page
S. M MacDonald
Symptom control: the problem areas
Palliative Medicine, April 1, 1994; 8(2): 167 - 168.
[PDF]


Home page
Hum Exp ToxicolHome page
E. Bodd, D. Jacobsen, E. Lund, Ås. Ripel, Jør. Mørland, and E. Wiik-Larsen
Morphine-6-Glucuronide might Mediate the Prolonged Opioid Effect of Morphine in Acute Renal Failure
Human and Experimental Toxicology, January 1, 1990; 9(5): 317 - 321.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.